Journal profile · ANATOMY & MORPHOLOGY-MEDICAL LABORATORY TECHNOLOGY

Applied immunohistochemistry & molecular morphology

ISSN 1541-2016 · eISSN 1533-4058 · Lippincott Williams and Wilkins Ltd. · UNITED STATES

Applied immunohistochemistry & molecular morphology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.27; JCR Q3 (journal website); hybrid open access; median 207 days to acceptance (89 articles, last 24 months); 54 articles in 2025; indexed in SCIE and Scopus.

Impact factor1.27Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time207 daysMedian, submission to acceptance · 89 articles, last 24 months · Crossref
APC—No source gives fee information
Acceptance—No reports yet
Articles per year542025 · OpenAlex count

Scope

Aims, scope and focus

Applied immunohistochemistry & molecular morphology is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are HER2/EGFR in Cancer Research, Sarcoma Diagnosis and Treatment and Molecular Biology Techniques and Applications, together about 23.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Applied Immunohistochemistry & Molecular Morphology covers newly developed identification and detection technologies, and their applications in research and diagnosis for the applied immunohistochemist & molecular Morphologist. Official Journal of the International Society for Immunohistochemisty and Molecular Morphology.

Source: LetPub

Research area (LetPub): ANATOMY & MORPHOLOGY-MEDICAL LABORATORY TECHNOLOGY

Editor-in-chief Andrew M BellizziPublisher website

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. HER2/EGFR in Cancer ResearchMedicine9.7%
  2. Sarcoma Diagnosis and TreatmentMedicine6.7%
  3. Molecular Biology Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology6.7%
  4. Lymphoma Diagnosis and TreatmentMedicine6.2%
  5. Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology6.1%
  6. Monoclonal and Polyclonal Antibodies ResearchMedicine5.1%
  7. Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology4.8%
  8. Genetic factors in colorectal cancerMedicine4.7%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorAnatomy & MorphologyZone 4
MinorMedical Laboratory TechnologyZone 4
MinorPathologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorAnatomy & MorphologyZone 4
MinorMedical Laboratory TechnologyZone 3
MinorPathologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorAnatomy & MorphologyZone 4
MinorMedical Laboratory TechnologyZone 4
MinorPathologyZone 4

Top journal: noReview journal: no

JCR / CiteScore quartiles on the journal's website

Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
1.27LetPub ·
Impact factor (publisher)
1.3Publisher website ·
CiteScore 2026-06
2.7LetPub ·
SJR 2026-06
0.47LetPub ·
SNIP 2026-06
0.52LetPub ·
h-index
55LetPub ·
h-index
77OpenAlex ·
i10-index
1,255OpenAlex ·
2-year mean citedness
1.18OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
14%LetPub ·

Volume

Articles per year
41LetPub ·

Articles by year OpenAlex count · 2,615 in total · the current year is incomplete

YearArticlesOpen accessCitations
202662188
202554766
20245912132
20238615336
20229324437
2021104211,059

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

207 daysMedian, submission to acceptance · P25–P75 139 days – 334 days

Acceptance to online
median 34 days (89 articles)
Submission to online
median 253 days
Sample
89 articles with submission and acceptance dates (134 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Lippincott Williams and Wilkins Ltd.
Country or region
UNITED STATES
Language
English
ISSN
1541-2016
Electronic ISSN
1533-4058
Latest issue on the website
Volume 34, Issue 5 (September 2026)
Official links

FAQ

Frequently asked questions about Applied immunohistochemistry & molecular morphology

What CAS zone is Applied immunohistochemistry & molecular morphology in?

In the 2025 upgraded edition of the CAS Journal Ranking, Applied immunohistochemistry & molecular morphology is in Zone 4 of Medicine, and in Zone 4 of the minor category Anatomy & Morphology / Medical Laboratory Technology / Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Applied immunohistochemistry & molecular morphology?

The latest impact factor listed by LetPub is 1.27; CiteScore 2.7, h-index 77.

How long does peer review take at Applied immunohistochemistry & molecular morphology?

Based on the dates recorded on 89 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 207 days (interquartile range 139–334 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What JCR quartile is Applied immunohistochemistry & molecular morphology in?

The journal's website gives JCR Q3; by category, ANATOMY & MORPHOLOGY Q3 (17/25), MEDICAL LABORATORY TECHNOLOGY Q4 (25/33), PATHOLOGY Q3 (64/89). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.

Which databases index Applied immunohistochemistry & molecular morphology?

According to LetPub and DOAJ records, Applied immunohistochemistry & molecular morphology is indexed in SCIE and Scopus.

Is Applied immunohistochemistry & molecular morphology open access, and what is the APC?

Applied immunohistochemistry & molecular morphology is a hybrid journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .